Literature DB >> 18600823

CD40L-expressing CD8 T cells prime CD8alpha(+) DC for IL-12p70 production.

Kok Loon Wong1, Fei Chuin Lew, Paul A MacAry, David M Kemeny.   

Abstract

CD8alpha(+) DC are implicated as the principle DC subset for cross-presentation and cross-priming of cytotoxic CD8 T cell responses. In this study, we demonstrate another unique facet of the CD8alpha(+) DC and CD8 T cell relationship, by showing that CD8 T cells reciprocally activate CD8alpha(+) DC, but not CD8alpha(-) DC, for IL-12p70 production, the key Th1-promoting cytokine. This effect was observed during an antigen-specific interaction between DC and activated CD8 T cells, along with secondary TLR stimulation of DC by LPS. Activated CD8 T cells use a combination of IFN-gamma and CD40L, which is rapidly up-regulated post-stimulation, to prime DC for IL-12p70 production during an antigen-specific response. Our results suggest that the interaction between CD8alpha(+) DC and antigen-primed CD8 T cells may form an important component of Th1-mediated immunity through the induction of IL-12p70.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600823     DOI: 10.1002/eji.200838199

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.

Authors:  Hongmei Li; Catherine Matte-Martone; Hung Sheng Tan; Srividhya Venkatesan; Jennifer McNiff; Anthony J Demetris; Dhanpat Jain; Fadi Lakkis; David Rothstein; Warren D Shlomchik
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

2.  CD40L expression permits CD8+ T cells to execute immunologic helper functions.

Authors:  Marco Frentsch; Regina Stark; Nadine Matzmohr; Sarah Meier; Sibel Durlanik; Axel R Schulz; Ulrik Stervbo; Karsten Jürchott; Friedemann Gebhardt; Guido Heine; Morgan A Reuter; Michael R Betts; Dirk Busch; Andreas Thiel
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

3.  Antigen-activated T cells induce IL-12p75 production from dendritic cells in an IFN-γ-independent manner.

Authors:  K Abdi; N J Singh
Journal:  Scand J Immunol       Date:  2010-12       Impact factor: 3.487

4.  CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

Authors:  Benoît P Nicolet; Aurélie Guislain; Floris P J van Alphen; Raquel Gomez-Eerland; Ton N M Schumacher; Maartje van den Biggelaar; Monika C Wolkers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

5.  Cutting Edge: Quantitative Determination of CD40L Threshold for IL-12 and IL-23 Production from Dendritic Cells.

Authors:  Kaveh Abdi; Karen Laky; Kartika Padhan; Constantinos Petrovas; Jeff Skinner; Juraj Kabat; David W Dorward; Joseph Brzostowski; Eric O Long; Giorgio Trinchieri; Rajat Varma
Journal:  J Immunol       Date:  2018-10-12       Impact factor: 5.422

Review 6.  Cooperativity of adaptive and innate immunity: implications for cancer therapy.

Authors:  Anil Shanker; Francesco M Marincola
Journal:  Cancer Immunol Immunother       Date:  2011-06-09       Impact factor: 6.968

7.  Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells.

Authors:  Prajwal Gurung; Tamara A Kucaba; Thomas A Ferguson; Thomas S Griffith
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  CD4+ T helper cells use CD154-CD40 interactions to counteract T reg cell-mediated suppression of CD8+ T cell responses to influenza.

Authors:  André Ballesteros-Tato; Beatriz León; Frances E Lund; Troy D Randall
Journal:  J Exp Med       Date:  2013-07-08       Impact factor: 14.307

9.  Priming of Salmonella enterica serovar typhi-specific CD8(+) T cells by suicide dendritic cell cross-presentation in humans.

Authors:  Rosângela Salerno-Goncalves; Marcelo B Sztein
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

10.  Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.

Authors:  Jeetendra Kumar; Vaijayanti Kale; Lalita Limaye
Journal:  Stem Cell Res Ther       Date:  2015-09-25       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.